Article
The Werner syndrome RECQ helicase as a therapeutic target: new insights.
Expert opinion on therapeutic targets - 1 Jan 2026
Sidorova Julia M, Monnat Raymond J
Abstract excerpt
INTRODUCTION: The WRN gene is mutated in Werner syndrome (WS), a heritable premature aging and cancer predisposition syndrome. Recent work identified WRN as a therapeutic target in a subset of cancers, emphasizing the need to better understand physiologic and cancer-specific roles for WRN that can be leveraged in therapy. AREAS COVERED: We discuss WRN as a caretaker of the genome that can function as a tumor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
